Stay updated on Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page
- Check5 days agoChange DetectedNo textual changes are recorded in the study history for this record. The history indicates the content remained unchanged across reviewed versions.SummaryDifference0.1%

- Check12 days agoChange DetectedThe study history now indicates recruitment is closed with 'No longer looking for participants,' and the log includes a new 'Revision: v3.6.0' entry alongside the deletion of 'Revision: v3.5.5.'SummaryDifference0.4%

- Check20 days agoChange DetectedThe study history page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a version update to the page's history metadata.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision entry 'Revision: v3.5.4' was added to the Record History and the previous entry 'Revision: v3.5.3' was removed. This reflects an update to the page version history rather than changes to the study content.SummaryDifference0.1%

- Check55 days agoChange DetectedNew revision v3.5.3 was added to the record history and the previous revision v3.5.2 was removed from the list. This update reflects ongoing maintenance of the study record's version history within the ClinicalTrials.gov workflow.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed from the record history.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.